Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - tablets - atogepant as monohydrate 10 mg - atogepant - qulipta is indicated for the preventive treatment of migraine in adults

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - tablets - atogepant as monohydrate 30 mg - atogepant - qulipta is indicated for the preventive treatment of migraine in adults

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - atogepant as monohydrate - tablets - atogepant as monohydrate 60 mg - atogepant - qulipta is indicated for the preventive treatment of migraine in adults

Malta - English - Medicines Authority

vale pharmaceuticals limited 3 anglesea street, clonmel, co. tipperary, e91 d6c5, ireland - clopidogrel - film-coated tablet - clopidogrel 75 mg - antithrombotic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance pharmaceuticals ltd - doxycycline hyclate - oral tablet - 20mg

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - caffeine 100mg (anhydrous); ergotamine tartrate 1mg;  ;   - tablet - 100 mg/1 mg - active: caffeine 100mg (anhydrous) ergotamine tartrate 1mg     excipient: iron oxide yellow magnesium stearate microcrystalline cellulose purified talc starch tartaric acid - treatment of acute attacks of migraine with or without aura in adults.

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - dapsone 100mg - tablet - 100 mg - active: dapsone 100mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - dermatitis herpetiformis.

New Zealand - English - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - dapsone 25mg - tablet - 25 mg - active: dapsone 25mg excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose - dermatitis herpetiformis.

New Zealand - English - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - glucagon hydrochloride 1mg (recombinant);  ;   - solution for injection - 1 mg - active: glucagon hydrochloride 1mg (recombinant)     excipient: lactose monohydrate water for injection - therapeutic treatment of severe hypoglycaemic reactions, which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents. to prevent the occurrence of secondary hypoglycaemia, oral carbohydrate should be given to restore the hepatic glycogen when the patient has responded to the treatment. the mechanism and hence treatment of sulfonylurea-induced hypoglycaemia differs from that of severe insulin-induced hypoglycaemia in some important ways. consciousness should preferably be restored by the administration of intravenous glucose. if glucagon is used due to the unavailability of intravenous glucose (e.g. before reaching a hospital) care should be taken to protect against secondary hypoglycaemia with constant monitoring of the patient's blood sugar level by medical personnel. subsequent administration of intravenous glucose may be required.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - glyceryl trinitrate 400ug - sublingual spray - 400 mcg/dose - active: glyceryl trinitrate 400ug excipient: ethanol norflurane peppermint oil - adults: treatment of acute angina pectoris. as well as relieving the pain of an acute attack, glytrin spray may be used prophylactically five to ten minutes prior to engaging in activities which may precipitate an acute attack.